Urology · Fort Worth, TX
NPI
1477549863
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5801 Oakbend Trl Ste 180
Fort Worth, TX, 76132
Phone (866) 367-8768
Groups this clinician bills Medicare through
Medicare paid, 2024
$298K
13,359 services
Medicare patients, 2024
1,228
Average age 75
Drug cost, 2024
$365K
3,374 prescriptions
Company payments, 2025
$1,140
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank H Moore III was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,256 times for 1,005 patients. In total Frank H Moore III billed 13,359 services in 110 codes, and Medicare paid $298K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,256 | 1,005 | $10.54 | $13K |
| 99214 Office E&M - Established | Office | 897 | 745 | $81.34 | $73K |
| 81002 Clinical Chemistry | Office | 877 | 669 | $3.39 | $2,972 |
| 36415 Venipuncture Blood Collection | Office | 566 | 465 | $8.64 | $4,890 |
| 51798 Ultrasound - Nonspecific | Office | 400 | 328 | $7.29 | $2,917 |
| 84153 Clinical Chemistry | Office | 393 | 360 | $17.90 | $7,034 |
| 81003 Clinical Chemistry | Office | 361 | 335 | $2.19 | $791 |
| 99213 Office E&M - Established | Office | 295 | 271 | $52.47 | $15K |
| 99204 Office E&M - New | Office | 206 | 206 | $101.25 | $21K |
| 52000 Cystourethroscopy | Office | 168 | 146 | $162.06 | $27K |
| 84154 Clinical Chemistry | Office | 164 | 154 | $17.86 | $2,929 |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 150 | 49 | $68.80 | $10K |
| 80048 Clinical Chemistry | Office | 132 | 122 | $8.29 | $1,094 |
| 85027 Blood Count | Office | 129 | 118 | $6.30 | $812 |
| 84403 Clinical Chemistry | Office | 110 | 101 | $24.95 | $2,744 |
By year: 2022 $322K for 6,727 services; 2023 $317K for 8,611 services; 2024 $298K for 13,359 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 877 | 669 | $3.39 | $2,972 |
| 36415 Venipuncture Blood Collection | 566 | 465 | $8.64 | $4,890 |
| 84153 Clinical Chemistry | 393 | 360 | $17.90 | $7,034 |
| 81003 Clinical Chemistry | 361 | 335 | $2.19 | $791 |
| 84154 Clinical Chemistry | 164 | 154 | $17.86 | $2,929 |
| 87801 Infectious Agent Detection by DNA/RNA | 150 | 49 | $68.80 | $10K |
| 80048 Clinical Chemistry | 132 | 122 | $8.29 | $1,094 |
| 85027 Blood Count | 129 | 118 | $6.30 | $812 |
| 84403 Clinical Chemistry | 110 | 101 | $24.95 | $2,744 |
| 87481 Infectious Agent Detection by DNA/RNA | 100 | 49 | $34.39 | $3,439 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank H Moore III prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 779 prescriptions and refills. In total Frank H Moore III wrote 3,374 Medicare prescriptions that cost $365K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 779 | 1,883 | 253 | $18K |
| Finasteride Generic | 506 | 1,345 | 164 | $5,961 |
| Tamsulosin Hcl Generic | 385 | 1,013 | 138 | $6,499 |
| Myrbetriq Mirabegron | 277 | 438 | 67 | $195K |
| Solifenacin Succinate Generic | 155 | 276 | 57 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 136 | 137 | 113 | $765 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 127 | 127 | 117 | $791 |
| Cephalexin Generic | 124 | 138 | 111 | $539 |
| Methenamine Hippurate Generic | 75 | 178 | 33 | $7,214 |
| Ciprofloxacin Hcl Generic | 68 | 68 | 54 | $558 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 61 | 122 | 12 | $916 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 61 | 61 | 48 | $549 |
| Dutasteride Generic | 47 | 120 | 15 | $1,637 |
| Testosterone Cypionate Generic | 45 | 81 | 17 | $1,768 |
| Gemtesa Vibegron | 44 | 96 | 16 | $44K |
Brand drugs: - claims; generic drugs: 3,016 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank H Moore III $1,140 ($1,140 in general payments such as food, travel and fees) from 14 companies. The largest payer was Astellas Pharma US Inc with $274.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 5 | $274 |
| Immunitybio, Inc. IBRX | 5 | $159 |
| Abbvie Inc. ABBV | 7 | $147 |
| Boston Scientific Corporation BSX | 1 | $129 |
| Dendreon Pharmaceuticals LLC | 2 | $81.47 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $81.32 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $62.48 |
| Urogen Pharma, Inc. URGN | 2 | $47.22 |
| Olympus America Inc. | 2 | $41.41 |
| Procept Biorobotics Corporation PRCT | 2 | $36.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.